Showing results (51-60 of 68) with videos related to

Sort By:
Pageof 7
ACS Medicinal Chemistry Letters|March 18, 2016
Discovery and Characterization of 2-Aminooxazolines as Highly Potent, Selective, and Orally Active TAAR1 AgonistsGuido Galley, Angélica Beurier, Guillaume Décoret, et al.
Angewandte Chemie (International Ed. in English)|March 16, 2021
"Host in Host" Supramolecular Core-Shell Type Systems Based on Giant Ring-Shaped PolyoxometalatesClément Falaise, Soumaya Khlifi, Pierre Bauduin, et al.
Expert Review of Vaccines|July 28, 2023
International adaptation and validation of the Pro-VC-Be: measuring the psychosocial determinants of vaccine confidence in healthcare professionals in European countriesAmanda Garrison, Linda Karlsson, Lisa Fressard, et al.
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|October 22, 2021
The four weeks before lockdown during the COVID-19 pandemic in Germany: a weekly serial cross-sectional survey on risk perceptions, knowledge, public trust and behaviour, 3 to 25 March 2020Cornelia Betsch, Lars Korn, Tanja Burgard, et al.
Bioorganic & Medicinal Chemistry Letters|October 27, 2010
Discovery of benzoylisoindolines as a novel class of potent, selective and orally active GlyT1 inhibitorsEmmanuel Pinard, Daniela Alberati, Markus Bender, et al.
Molecular Cancer|July 8, 2023
Combined proteomics and CRISPR‒Cas9 screens in PDX identify ADAM10 as essential for leukemia in vivoEhsan Bahrami, Jan Philipp Schmid, Vindi Jurinovic, et al.
BMC Public Health|July 18, 2018
Increasing influenza and pneumococcal vaccine uptake in the elderly: study protocol for the multi-methods prospective intervention study Vaccination60Cornelia Betsch, Constanze Rossmann, Mathias W Pletz, et al.
Science Communication|November 23, 2023
Science Communication as a Collective Intelligence Endeavor: A Manifesto and Examples for ImplementationDawn Holford, Angelo Fasce, Katy Tapper, et al.
Nature Communications|September 28, 2021
In vivo inducible reverse genetics in patients' tumors to identify individual therapeutic targetsMichela Carlet, Kerstin Völse, Jenny Vergalli, et al.
Journal of Medicinal Chemistry|May 25, 2010
Selective GlyT1 inhibitors: discovery of [4-(3-fluoro-5-trifluoromethylpyridin-2-yl)piperazin-1-yl][5-methanesulfonyl-2-((S)-2,2,2-trifluoro-1-methylethoxy)phenyl]methanone (RG1678), a promising novel medicine to treat schizophreniaEmmanuel Pinard, Alexander Alanine, Daniela Alberati, et al.
Pageof 7